SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-117932
Filing Date
2016-05-05
Accepted
2016-05-05 18:33:04
Documents
2
Period of Report
2016-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6251
2 EX-99.1 DOCUMENT attachment1.htm EX-99.1 2627
  Complete submission text file 0001209191-16-117932.txt   11387
Mailing Address 3052 PACIFIC AVENUE SAN FRANCISCO CA 94115
Business Address
Tananbaum James B. (Reporting) CIK: 0001581754 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161625421

Mailing Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111
Business Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Management III, LLC (Reporting) CIK: 0001645157 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161625423

Mailing Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111
Business Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund III, L.P. (Reporting) CIK: 0001645158 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161625422

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances